In one of the biggest breakthroughs in schizophrenia research in recent times, Professor Cynthia Shannon Weickert at Neuroscience Research Australia (NeuRA) has identified immune cells in greater amounts in the brains of some people with schizophrenia. The study published today in Molecular Psychiatry has the potential to transform global schizophrenia research and open new avenues for developing targeted immune cell therapies.
One in every 100 Australians lives with schizophrenia. No single cause of schizophrenia has been identified, and this has prevented the development of a cure. The current treatments for schizophrenia are designed to suppress symptoms rather than target underlying causes of the disorder. These drugs only partially relieve symptoms and can produce unwanted side effects.
To recognise the significance of this discovery Professor Shannon Weickert says you first need to understand most scientists have had a long held belief that immune cells were independent from the brain pathology in psychotic illnesses.
“In our study, we challenged this assumption that immune cells were independent of the brain in psychiatric illness and made an exciting discovery. We identified immune cells as a new player in the brain pathology of schizophrenia,” said Professor Shannon Weickert.
Current schizophrenia research has focused on the status of three brain cells: the neurons; the glial cells, which support the neurons; and the endothelial cells, which coat the blood vessels. Employing new molecular techniques allowed Professor Shannon Weickert and her team to identify the presence of a fourth cell, the macrophage, a type of immune cell in the brain tissue of people with schizophrenia who show high levels of inflammation.
Professor Shannon Weickert said immune cells have previously been ignored as they had long been viewed simply as travelers just thought to be passing by, undertaking surveillance work. They have never been a suspect until now.
“To find immune cells along the blood brain barrier in increased amounts in people with schizophrenia is an exciting discovery. It suggests immune cells themselves may be producing these inflammatory signals in the brains of people living with schizophrenia,” said Professor Shannon Weickert.
“We have observed in people with schizophrenia, the glial cells, one of the local residents, become inflamed and produce distress signals which change the status of the endothelial cells.
“We think this may cause the endothelial cells to extend sticky tentacles, so when the immune cells travel by some are captured. These cells may transmigrate across the blood brain barrier entering the brain in greater amounts in some people with schizophrenia compared to people without the disorder.”
This discovery shows that specific immune cells are in the brains of some people with schizophrenia in close enough proximity to the neurons to do damage.
Professor Peter Schofield, CEO of NeuRA said this innovative new research has the ability to alter the way in which we may be able to diagnose and treat schizophrenia.
“This breakthrough demonstrates the value of the NSW Government’s support for Professor Shannon Weickert as NSW Chair of Schizophrenia Research, which has delivered new insights that the community seeks,” said Professor Schofield.
Professor Shannon Weickert is encouraging a cross-collaborative approach between neuroscientists and immunologists globally, to work together to develop treatments targeting this abnormal immune pathology of schizophrenia.
“This opens whole new avenues for therapy, because it suggests that the pathology of schizophrenia could be within the immune cells and the immune cells could be contributing to the symptoms of schizophrenia,” said Professor Shannon Weickert.
Professor Shannon Weickert is uniquely motivated in her work, with her twin-brother being diagnosed with schizophrenia when he was 17 years old.
Learn more: Schizophrenia breakthrough
The Latest on: Schizophrenia
via Google News
The Latest on: Schizophrenia
- TAU Researchers Find Common Gene Mutation Mechanism in Autism, Schizophreniaon May 24, 2022 at 1:21 am
An experimental drug developed at a TAU lab may be suitable for treating a range of rare syndromes that impair brain functions.
- World Schizophrenia Day: Common symptoms, causes and all you want to know about the mental disorderon May 24, 2022 at 12:36 am
Schizophrenia affects 24 million people or 1 in 300 people worldwide. It is a disorder where people may find it difficult to differentiate between reality and imagination.
- It's not easy to notice symptoms of schizophrenia in an early stage. Hallucination, delusion and other signs to watch out foron May 23, 2022 at 11:53 pm
Although that doesn’t mean that their loved ones should lose hope, because there are always alternative treatments that may prove to be beneficial, it certainly means that early diagnosis and ...
- How to tackle stigma around schizophreniaon May 23, 2022 at 7:23 pm
Individuals with schizophrenia are not aggressive. Rather they often become the victims of violence, abuse and fraud.
- Brother's struggle with schizophrenia led local nurse to focus on mental healthon May 23, 2022 at 2:14 pm
Although Bonnie Sandy started in nursing at the age of 16, her brother's battle against schizophrenia changed the direction.
- Government help, social support lacking for schizophrenia patients: Expertson May 23, 2022 at 1:15 pm
PGIMER doctor says around half the schizophrenia patients drop out of treatment prematurely amid proper awareness, while also highlighting lack of government help and social support ...
- A touching account of one American family’s struggle with schizophreniaon May 21, 2022 at 9:27 am
On the surface, the Galvins were the model American family. Parents Mimi and Don lived in Colorado Springs in the 1950s and 60s and had 12 children, 10 boys and two girls. Don Galvin was an instructor ...
- World Schizophrenia Day: Living with the mental illnesson May 20, 2022 at 1:46 am
Dealing with schizophrenia can be tough. I have learnt to accept this reality," says a 52-year-old woman as she recalls the closed chapter of her ambition to soar the skies as a pilot. World ...
- Repeated DNA sequences in the genome may contribute to schizophrenia riskon May 12, 2022 at 5:00 pm
Researchers at The Hospital for Sick Children (SickKids) and Centre for Addiction and Mental Health (CAMH) have found that repeated DNA sequences in the genome may contribute to an individual's risk ...
via Bing News